Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 31 Neoplasms 13 Stomach Neoplasms 11 Lung Neoplasms 11 Endometrial Neoplasms 11 Lymphatic Metastasis 7 Head and Neck Neoplasms 7 Carcinoma, Hepatocellular 7 Melanoma 6 Esophageal Neoplasms 6 Uterine Cervical Neoplasms 5 Rectal Neoplasms 5 Colonic Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Ovarian Neoplasms 4 Brain Neoplasms 4 Vulvar Neoplasms 3 Sarcoma 3 Prostatic Neoplasms 3 Lymphedema 3 Colorectal Neoplasms 3 Thyroid Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Solitary Pulmonary Nodule 2 Skull Base Neoplasms 2 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Peritoneal Neoplasms 2 Osteosarcoma 2 Multiple Pulmonary Nodules 2

Interventions

Cyclophosphamide 155 Dexamethasone 141 Rituximab 85 fludarabine 80 Lenalidomide 72 Cytarabine 70 Bortezomib 65 fludarabine phosphate 63 Gemcitabine 62 venetoclax 55 pomalidomide 53 Etoposide 53 pembrolizumab 52 Paclitaxel 48 Cisplatin 48 Carboplatin 48 Peripheral Blood Stem Cell Transplantation 47 Filgrastim 40 Radiotherapy 39 Busulfan 37 Calcium Dobesilate 36 Methotrexate 34 Melphalan 34 Bevacizumab 33 carfilzomib 32 Cyclosporine 32 Azacitidine 32 Mycophenolic Acid 30 Vincristine 29 Bendamustine Hydrochloride 29

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × Indocyanine Green × Clear all

NCT02920216 2022-03-31

SALVADS-Fluo

Institut de Cancérologie de Lorraine

Phase NA Completed

Head and Neck Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡